Migraine and Headache Studies
Peer reviewed
Scollr summary
What this paper is about
CGRP mAbs were associated with substantial reductions in migraine frequency; however, achieving optimal control and migraine freedom remains challenging in real-world practice, particularly in patients with a higher baseline burden.
Full abstract
Read the full abstract
ObjectiveTo evaluate the achievement of the International Headache Society (IHS) higher standards for migraine prevention in patients treated with calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) in real-world practice.MethodsWe retrospectively analyzed 307 migraine patients treated with CGRP mAbs at a single center. Monthly migraine days (MMDs) were assessed at baseline and during follow-up (1-24 months). According to IHS recommendations, migraine control was categorized as optimal ( 6 days/month). Patients were further classified by the timing of achieving optimal control.ResultsThe percentage of patients achieving a ≥ 50% reduction in MMDs increased from 36.2% at month 1 to 71.0% at month 24; optimal control increased from 15.0% to 38.8%. Among patients with a ≥ 50% response, 38.7-55.7% achieved optimal control during follow-up. Migraine freedom remained relatively uncommon (1.6-10.1%). Patients who achieved optimal control early (≤3 months) had a lower baseline migraine burden, whereas nonachievers had a higher baseline disease burden and more prior preventive treatment failures.ConclusionsCGRP mAbs were associated with substantial reductions in migraine frequency; however, achieving optimal control and migraine freedom remains challenging in real-world practice, particularly in patients with a higher baseline burden.
Direct answer
What can I do from this paper page?
Use this page to scan "Real-world achievement of higher standards for migraine prevention with CGRP monoclonal antibodies" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Migraine and Headache Studies research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Suzuki2026Real,
title = {Real-world achievement of higher standards for migraine prevention with CGRP monoclonal antibodies},
author = {Keisuke Suzuki and Shiho Suzuki and Saro Kobayashi and Mukuto Shioda and Hiroaki Fujita and Yasuo Haruyama and Ryotaro Hida and Koichi Hirata},
journal = {Cephalalgia},
year = {2026},
doi = {10.1177/03331024261453284},
url = {https://doi.org/10.1177/03331024261453284}
}FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Migraine and Headache Studies research papers?
Follow Migraine and Headache Studies research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Real-world achievement of higher standards for migraine prevention with CGRP monoclonal antibodies. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app